Doxil liposomal doxorubicin data

Researchers presented results of Phase III trials of Doxil as first line therapy for KS in

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE